Disclaimer: The information contained on this page has been submitted by the Author. As such, the responsibility of content remains with the Author and is not an official statement from EMAS.This material is to be used for educational purposes only and is not intended for commercial use. No information may be copied or cited without prior consent from the Author. The products mentioned are not necessarily endorsed by the Author. For any further information, please contact the EMAS secretariat.
eMAS lectures at IMS June 2011
Treatment of menopausal symptoms in breast cancer survivors S. Rozenberg
Risk factors and prevalence of women's health cancers in Europe S. Rozenberg
Menopausal Symptoms as markers of CVD disease susceptibility M. Gambacciani
Management of Osteoporosis in Europe I. Lambrinoudaki
Subclinical CVD I. Lambrinoudaki
eMAS lectures at vienna 2010
Obesity and cardiovascular disease epidemics: a time for reflection. M.Rees
Alternative treatment of hot flashes from an evidence based perspective. M. Moen
COMING SOON
Breast cancer: evolution of incident rates in Europe in relation to HRT? S. Rozenberg
EMAS lecture at EBCOG, Antwerp, May 2010
HRT & CHD is there evidence for a window of opportunity? Dr.Marco Gambacciono
Should osteoporosis prevention start at the menopause or should we only target women at high risk? Prof.Marc Brincat, Dr.J.Calleja-Agius
Making sense of HT after menopause: is there a place for HT in view of the stroke risk? Prof.Serge Rozenberg
Is postmenopause hormone therapy acceptable in view of breast cancer risk? Dr.Irene Lambrinoudaki
8th European Congress on Menopause, 16-20 May 2009, London, UK
Plenary Lectures
Monday, 18 May, 2009
An aging world- Challenges ahead B. Lunenfeld,
Israel
Debates
Monday, 18 May, 2009
DEBATE: PROGESTIN OR PROGESTERONE – THERE IS NO REAL DIFFERENCE Introduction A. Gompel, France
Progestin or progesterone - There is no real difference M. Dören, Germany
Progesterone and progestins: There are real differences J. Desreux, A. Béliard, E. Lifrange, J.-M. Foidart, Belgium
Tuesday, 19 May, 2009
DEBATE: LONG-TERM PREVENTION OF OSTEOPOROSIS STARTING AT THE MENOPAUSE IS PREFERABLE TO LATER TARGETING OF WOMEN AT HIGH FRACTURE RISK Long -term prevention of osteoporosis starting at the menopause
is preferable to later targeting of women at a high fracture risk C. Christiansen,
Denmark
Parallel Sessions
Sunday, 17 May, 2009
PARALLEL SESSION: BREAST MANAGEMENT Managing oestrogen deficiency after breast cancer S. Rozenberg, C. Antoine, B. Carly, F. Liebens,
Belgium PARALLEL SESSION: OBESITY AND HEALTH IN POST-MENOPAUSAL WOMEN Obesity-a silent killer? R. Kaaks,
Germany Impact of obesity on symptoms of the menopause M.A. Lumsden,
UK Management of obesity in menopause G. Mastorakos, G. Paltoglou,
Greece
PARALLEL SESSION: THE AGEING MALE - LATE ONSET HYPOGONADISM (LOH) Safety W. Weidner, Germany
ISSAM recommendations for the management of late onset hypogonadism B. Lunenfeld, Israel
PARALLEL SESSION: HRT & BREAST CANCER RISK Decrease in breast cancer incidence and HRT A. Gompel, G. Plu-Bureau, France
What is the impact of HRT on screening B. von Schoultz, Sweden
PARALLEL SESSION: NEW DEVELOPMENTS FOR TOMORROW Contribution of molecular biology tools M. Ivan, USA
PARALLEL SESSION: URO-GENITAL AGEING Managing URO-genital atrophy G. Samsioe, Sweden
Maintaining standards in surgery for female urinary incontinence P. Riss, Austria
Monday, 18 May, 2009
PARALLEL SESSION: PERIMENOPAUSE Contraception after 45 A. Szarewski, UK
Aetiology of premature ovarian failure S. Vujovic, Serbia
Managing premature ovarian failure N. Panay, UK
Tuesday, 19 May, 2009
PARALLEL SESSION: SEXUAL FUNCTION Sexuality in older couples M. Lachowsky,
France
PARALLEL SESSION: PROFESSIONAL DEVELOPMENT IN MENOPAUSE PRACTICE - EUROPE UK special interest training in menopause S. Gray, UK
Training for menopause practice in Scandinavia M.H. Moen, Norway
PARALLEL SESSION: CARDIOVASCULAR DISEASE Is there really a window of opportunity? J.C. Stevenson, UK
The risk of stroke in postmenopausal women receiving hormonal therapy R.A. Lobo, USA
PARALLEL SESSION: SEXUAL HEALTH Improving immunity in the climateric years F. Al-Azzawi, UK
PARALLEL SESSION: THE MENOPAUSAL UTERUS AND OVARY Understanding uterine bleeding M. Rees, UK
Benign gynaecology after menopause H. Retto, Portugal
Wednesday, 20 May, 2009
PARALLEL SESSION: OSTEOPOROSIS AND FRACTURE Advances in non-hormonal drug therapy for fracture preventionE. Dennison,
UK Vertebral body quality, effect of HRT and fracture prevention in osteoporosis M. Brincat, J. Calleja-Agius, Y. Muscat-Baron,
Malta
PARALLEL SESSION: INDIVIDUALISING THERAPY FOR CLIMACTERIC SYMPTOMS Vasomotor symptoms
D. Sturdee, UK
Joint aches & pains: individualising therapy for climacteric symptoms M. Gambacciani,
Italy